Ann: Quarterly Results and Investor Conference Call Notification, page-24

"..................we're talking purely the Dx app (for pneumonia etc...), it depends on the agreement between ResApp and the provider (i.e. Medgate, Alodokter, Coviu etc)............."

Many thanks for that prompt response fb. OK get the channel/s they are chasing but assume no signed agreements yet. Understand and basically agree with the no vote but frankly suggest this offer is not even based on the current SP. Pfizer initial offer based on a MC of $100 mil is sort of similar to a BP making an offer for a product at stage II trial stage (still not totally derisked). Offer is low as the target (RAP) does not actually have the hard data in the bag to be able to use in negotiations. Been suggested BoD is having a bit of a bet each way. If the no vote wins they still pick up the extra funds from Pfizer and continue the game. On the other hand if the yes vote gets up they have flipped the business and walk away with a pocket full of coins. Cynical but certainly a potential scenario depending on their thought processes of being able to take this all the way to market. If this in fact is not the first offer but one that is a result of negotiation then it may not be good news for the SH's. The other edge of the sword to a successful no vote is that no other BP comes to the table and no further offer is made by Pfizer. We live in interesting times. GLTAH